miR‐21‐5p promotes cell proliferation and G1/S transition in melanoma by targeting CDKN2C-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

miR‐21‐5p promotes cell proliferation and G1/S transition in melanoma by targeting CDKN2C

Published:2020-03-24 Issue:5 Volume:10 Page:752-760
ISSN:2211-5463
Container-title:FEBS Open Bio
language:en
Short-container-title:FEBS Open Bio

Author:

Yang Zhaohui¹,Liao Bo²,Xiang Xiaoyan¹,Ke Sha³^ORCID

Affiliation:

1. Department of Burns and Plastic Surgery Affiliated Hospital of North Sichuan Medical College Nanchong China

2. Department of Urology Affiliated Hospital of North Sichuan Medical College Nanchong China

3. Department of Neurology Affiliated Hospital of North Sichuan Medical College Nanchong China

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/2211-5463.12819

Reference32 articles.

1. Novel Approaches to Treatment of Advanced Melanoma: A Review on Targeted Therapy and Immunotherapy

2. Plasma MicroRNA Levels Following Resection of Metastatic Melanoma

3. Melanoma Adjuvant Therapy

4. Metastatic Melanoma: Insights Into the Evolution of the Treatments and Future Challenges

5. MicroRNAs: Target Recognition and Regulatory Functions

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Characterization of two melanoma cell lines resistant to BRAF/MEK inhibitors (vemurafenib and cobimetinib);Cell Communication and Signaling;2024-08-23

2. Advances in Melanoma: From Genetic Insights to Therapeutic Innovations;Biomedicines;2024-08-14

3. CBX8 promotes lung adenocarcinoma growth and metastasis through transcriptional repression of CDKN2C and SCEL;Journal of Cellular Physiology;2023-09-21

4. A group of three miRNAs can act as candidate circulating biomarkers in liquid biopsies from melanoma patients;Frontiers in Medicine;2023-06-14

5. HNRNPA2B1-mediated m6A modification of lncRNA MEG3 facilitates tumorigenesis and metastasis of non-small cell lung cancer by regulating miR-21-5p/PTEN axis;Journal of Translational Medicine;2023-06-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3